bioAffinity Technologies (BIAF) News Today $0.29 +0.01 (+2.89%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.28 0.00 (-1.04%) As of 08/8/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period bioAffinity’s CyPath® Lung Test Detects Early CancerAugust 1, 2025 | msn.combioAffinity Technologies Announces Notification of China Patent Award for Company's Noninvasive Lung Cancer DiagnosticJuly 15, 2025 | businesswire.comBIAF | bioAffinity Technologies Inc. Annual Income Statement - MarketWatchJuly 9, 2025 | marketwatch.comCase Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive ImagingJuly 9, 2025 | finance.yahoo.combioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference - MorningstarJune 27, 2025 | morningstar.comMbioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics ConferenceJune 26, 2025 | finance.yahoo.combioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership BoardJune 11, 2025 | finance.yahoo.combioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® LungJune 3, 2025 | finance.yahoo.comBioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 ReceptorsMay 29, 2025 | msn.combioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer TherapeuticsMay 28, 2025 | finance.yahoo.comBioAffinity Technologies announces pricing of $3.25M offeringMay 7, 2025 | finance.yahoo.comBioAffinity Technologies announces pricing of $3.25M offeringMay 7, 2025 | finance.yahoo.combioAffinity Technologies Announces Closing of $3.25 Million OfferingMay 7, 2025 | businesswire.comWallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m OfferingMay 7, 2025 | prnewswire.combioAffinity Technologies Announces Pricing of $3.25 Million OfferingMay 6, 2025 | businesswire.comTop Stock Reports for Alphabet, Berkshire Hathaway & VisaMay 5, 2025 | msn.comMaxim Group Downgrades bioAffinity Technologies (BIAF)April 2, 2025 | msn.combioAffinity Technologies Reports Record $9.4 Million Revenue for 2024March 31, 2025 | businesswire.combioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVMarch 28, 2025 | markets.businessinsider.comBIOAFFINITY TECHNOLOGIES Earnings Preview: Recent $BIAF Insider Trading, Hedge Fund Activity, and MoreMarch 27, 2025 | nasdaq.comCase Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung CancerMarch 26, 2025 | finance.yahoo.comSA biotech plans big cuts to grow core companyMarch 7, 2025 | bizjournals.comWallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 MillionFebruary 26, 2025 | prnewswire.combioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 MillionFebruary 26, 2025 | businesswire.comWallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 MillionFebruary 25, 2025 | prnewswire.combioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 MillionFebruary 25, 2025 | businesswire.combioAffinity Technologies faces Nasdaq delisting over priceFebruary 8, 2025 | msn.comBioAffinity patent application accepted by IP Australia for early stage LC testJanuary 23, 2025 | markets.businessinsider.combioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® LungJanuary 13, 2025 | finance.yahoo.comEnlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TVJanuary 10, 2025 | finanznachrichten.debioAffinity Technologies Reports Strong Q3 GrowthNovember 15, 2024 | markets.businessinsider.combioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024November 14, 2024 | finanznachrichten.debioAffinity Technologies Announces Award of Japanese Patent for CyPath® LungOctober 31, 2024 | finance.yahoo.comBioAffinity Technologies announces closing of $2.6M registered direct offeringOctober 22, 2024 | markets.businessinsider.comWallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private PlacementOctober 21, 2024 | prnewswire.combioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private PlacementOctober 21, 2024 | finance.yahoo.combioAffinity Technologies (NASDAQ:BIAF) Stock Quotes, Forecast and News SummaryOctober 19, 2024 | benzinga.combioAffinity VP contributes to new cytometry guidelinesOctober 18, 2024 | uk.investing.combioAffinity's CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry GuidelinesOctober 18, 2024 | stockhouse.combioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private PlacementOctober 18, 2024 | businesswire.comBioAffinity Technologies Down 25% on Stock Sale, Warrant Private PlacementOctober 18, 2024 | marketwatch.combioAffinity Technologies Inc BIAFOctober 18, 2024 | morningstar.comMWallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private PlacementOctober 18, 2024 | prnewswire.comLung cancer spit test fast-tracks a San Antonio biotech company for growthOctober 12, 2024 | msn.combioAffinity Technologies Names J. Michael Edwards as Chief Financial OfficerOctober 10, 2024 | finance.yahoo.combioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath ® Lung TestOctober 9, 2024 | businesswire.comWallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionAugust 5, 2024 | prnewswire.comWallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionAugust 2, 2024 | prnewswire.comMaxim Group Initiates Coverage of bioAffinity Technologies (BIAF) with Buy RecommendationJuly 24, 2024 | msn.combioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsJune 12, 2024 | businesswire.com Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address BIAF Media Mentions By Week BIAF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAF News Sentiment▼0.000.38▲Average Medical News Sentiment BIAF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAF Articles This Week▼01▲BIAF Articles Average Week Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ReShape Lifesciences News Today CISO Global News Today Scienjoy News Today Luna Innovations News Today Data Storage News Today XBP Europe News Today Mobiquity Technologies News Today FlexShopper News Today Stran & Company, Inc. News Today comScore News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIAF) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIAF Stock Alerts